Clinical Trials Insight: 700028379

Trial Profile

Clinical Trials Insight: 700028379

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Nov 2007

At a glance

  • Drugs FT 105; Insulin glargine
  • Indications Diabetes mellitus; Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Flamel Technologies
  • Most Recent Events

    • 13 Nov 2007 New trial record.
    • 19 Oct 2007 Preliminary results reported in a Falmel Technologies media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top